Found 21 matching trials
Pulse Wave Velocity, Tacrolimus Time in Therapeutic Range and CV in African American Kidney Transplants PHASE4 The primary purpose of this study is to evaluate the pulse wave velocity an...
Show More Status
Active Not Recruiting
Location
Hospital of the University of Pennsylvania
Learn More & Join Trial
ATG Versus Basiliximab in Kidney Transplant Displaying Low Immunological Risk But High Susceptibility to DGF PHASE4 The primary objective of the following randomized open label trial is to de...
Show More Location
Universitary hospital of Lyon
Learn More & Join Trial
Thymoglobulin® Pharmacokinetics in Patients Undergoing Hematopoietic Stem Cell Transplantation PHASE4 Thymoglobulin is widely applied as serotherapy in order to prevent acute gr...
Show More Location
Institut d'Hématologie et d'Oncologie Pédiatrique
Learn More & Join Trial
Randomized HaploCord Blood Transplantation vs. Double Umbilical Cord Blood Transplantation for Hematologic Malignancies PHASE2 The purpose of this study is compare the efficacy of haplo-cord transplant ...
Show More Location
Weill Cornell Medical College
Learn More & Join Trial
Pediatric Study of GVHD Ppx w/o Calcineurin Inhibitors After Day60 Post First Allo HSCT for Hematological Malignancies. PHASE2 The participants are being asked to take part in this clinical trial becaus...
Show More Location
St. Jude Children's Research Hospital
Learn More & Join Trial
Antibody and Delayed Cyclosporine Versus Initial Cyclosporine Alone in Patients Receiving Kidney Transplants NA The purpose of this study is to see if kidney function can be improved duri...
Show More Location
Ilene Blechman-Krom
Learn More & Join Trial
Sirolimus, Tacrolimus, Thymoglobulin and Rituximab as Graft-versus-Host-Disease Prophylaxis in Patients Undergoing Haploidentical and HLA Partially Matched Donor Hematopoietic Cell Transplantation PHASE2 This Phase II clinical trial was designed for patients with hematologic mal...
Show More Location
Karmanos Cancer Institute
Learn More & Join Trial
Induction in Sensitized Kidney Transplant Recipients Without Pre-existing Donor-specific antiboDies PHASE3 Induction therapy decreases the rate of acute allograft rejection in kidney...
Show More Learn More & Join Trial
Targeting the IPA and Matching for the Non-Inherited Maternal Antigen for Haplo-Cord Transplantation PHASE2 In this trial, we aim to improve the outcomes of haplo cord transplant. Hap...
Show More Location
University of Chicago Medical Center
Learn More & Join Trial
Allogeneic Stem Cell Transplantation Followed By Targeted Immune Therapy In Average Risk Leukemia PHASE1 Allogeneic stem cell transplantation (AlloSCT) followed by targeted immune ...
Show More Location
Columbia University Medical Center
Learn More & Join Trial